ArticleERJ open research2021

Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease.

Robin Deterding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.